Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04505657
Status:
COMPLETED
Last Update Posted:
2021-09-29
First Post:
2020-08-06
Brief Title:
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography
Sponsor:
Aswan University Hospital
Organization:
Aswan University Hospital
Study Overview
Official Title:
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2021-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
our aims to investigate the effectiveness of10 Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography
Detailed Description:
hysterosalpingography can cause pain and discomfort in several ways Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion trans-cervical actions including measuring uterine depth inserting the cannula and injection of the dye
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None